86 related articles for article (PubMed ID: 26965511)
1. Amide proton transfer (APT) magnetic resonance imaging of prostate cancer: comparison with Gleason scores.
Takayama Y; Nishie A; Sugimoto M; Togao O; Asayama Y; Ishigami K; Ushijima Y; Okamoto D; Fujita N; Yokomizo A; Keupp J; Honda H
MAGMA; 2016 Aug; 29(4):671-9. PubMed ID: 26965511
[TBL] [Abstract][Full Text] [Related]
2. Amide proton transfer-weighted imaging with a short acquisition time based on a self B0 correction using the turbo spin echo-Dixon method: A phantom study.
Tokunaga C; Wada T; Togao O; Kobayashi K; Kato T
Magn Reson Imaging; 2024 Jul; 110():69-77. PubMed ID: 38614223
[TBL] [Abstract][Full Text] [Related]
3. Amide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy response.
Dula AN; Arlinghaus LR; Dortch RD; Dewey BE; Whisenant JG; Ayers GD; Yankeelov TE; Smith SA
Magn Reson Med; 2013 Jul; 70(1):216-24. PubMed ID: 22907893
[TBL] [Abstract][Full Text] [Related]
4. Amide proton transfer-weighted magnetic resonance imaging for application in renal fibrosis: A radiological-pathological based analysis.
Zhao D; Wang W; Niu YY; Ren XH; Shen AJ; Xiang YS; Xie HY; Wu LH; Chen Y; Zhang YY
Am J Nephrol; 2024 Jan; ():. PubMed ID: 38228096
[TBL] [Abstract][Full Text] [Related]
5. Intra-individual comparison of (68)Ga-PSMA-11-PET/CT and multi-parametric MR for imaging of primary prostate cancer.
Giesel FL; Sterzing F; Schlemmer HP; Holland-Letz T; Mier W; Rius M; Afshar-Oromieh A; Kopka K; Debus J; Haberkorn U; Kratochwil C
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1400-6. PubMed ID: 26971788
[TBL] [Abstract][Full Text] [Related]
6. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
[TBL] [Abstract][Full Text] [Related]
7. Impact of multiparametric magnetic resonance imaging on risk group assessment of patients with prostate cancer addressed to external beam radiation therapy.
Pullini S; Signor MA; Pancot M; Zuiani C; Bazzocchi M; Fongione S; Girometti R
Eur J Radiol; 2016 Apr; 85(4):764-70. PubMed ID: 26971421
[TBL] [Abstract][Full Text] [Related]
8. Assessment of PI-RADS v2 for the Detection of Prostate Cancer.
Kasel-Seibert M; Lehmann T; Aschenbach R; Guettler FV; Abubrig M; Grimm MO; Teichgraeber U; Franiel T
Eur J Radiol; 2016 Apr; 85(4):726-31. PubMed ID: 26971415
[TBL] [Abstract][Full Text] [Related]
9. Comparison of prostate cancer detection at 3-T MRI with and without an endorectal coil: A prospective, paired-patient study.
Costa DN; Yuan Q; Xi Y; Rofsky NM; Lenkinski RE; Lotan Y; Roehrborn CG; Francis F; Travalini D; Pedrosa I
Urol Oncol; 2016 Jun; 34(6):255.e7-255.e13. PubMed ID: 26971190
[TBL] [Abstract][Full Text] [Related]
10. Chemical exchange saturation transfer magnetic resonance imaging and its main and potential applications in pre-clinical and clinical studies.
Dou W; Lin CE; Ding H; Shen Y; Dou C; Qian L; Wen B; Wu B
Quant Imaging Med Surg; 2019 Oct; 9(10):1747-1766. PubMed ID: 31728316
[TBL] [Abstract][Full Text] [Related]
11. APT-weighted MRI: Techniques, current neuro applications, and challenging issues.
Zhou J; Heo HY; Knutsson L; van Zijl PCM; Jiang S
J Magn Reson Imaging; 2019 Aug; 50(2):347-364. PubMed ID: 30663162
[TBL] [Abstract][Full Text] [Related]
12. [Progress in Clinical Research of Amide Proton Transfer Imaging].
Jia X; Lai C; Ma X
Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Feb; 44(2):185-188. PubMed ID: 32400996
[TBL] [Abstract][Full Text] [Related]
13. Amide proton transfer imaging of tumors: theory, clinical applications, pitfalls, and future directions.
Kamimura K; Nakajo M; Yoneyama T; Takumi K; Kumagae Y; Fukukura Y; Yoshiura T
Jpn J Radiol; 2019 Feb; 37(2):109-116. PubMed ID: 30341472
[TBL] [Abstract][Full Text] [Related]
14. Amide proton transfer imaging has added value for predicting extraprostatic extension in prostate cancer patients.
Qin X; Lv J; Zhang J; Mu R; Zheng W; Liu F; Huang B; Li X; Yang P; Deng K; Zhu X
Front Oncol; 2024; 14():1327046. PubMed ID: 38496759
[TBL] [Abstract][Full Text] [Related]
15. B1 Power Modification for Amide Proton Transfer Imaging in Parotid Glands: A Strategy for Image Quality Accommodation and Evaluation of Tumor Detection Feasibility.
Wu X; Su T; Chen Y; Xu Z; Wang X; Hu G; Wang Y; Wong LM; Zhang Z; Zhang T; Jin Z
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473250
[TBL] [Abstract][Full Text] [Related]
16. Comparison and combination of amide proton transfer magnetic resonance imaging and the apparent diffusion coefficient in differentiating the grades of prostate cancer.
Qin X; Mu R; Zheng W; Li X; Liu F; Zhuang Z; Yang P; Zhu X
Quant Imaging Med Surg; 2023 Feb; 13(2):812-824. PubMed ID: 36819246
[TBL] [Abstract][Full Text] [Related]
17. CEST-MRI for body oncologic imaging: are we there yet?
Vinogradov E; Keupp J; Dimitrov IE; Seiler S; Pedrosa I
NMR Biomed; 2023 Jun; 36(6):e4906. PubMed ID: 36640112
[TBL] [Abstract][Full Text] [Related]
18. Amide Proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study.
Yang L; Wang L; Tan Y; Dan H; Xian P; Zhang Y; Tan Y; Lin M; Zhang J
Cancer Imaging; 2023 Jan; 23(1):3. PubMed ID: 36611191
[TBL] [Abstract][Full Text] [Related]
19. Emerging MR methods for improved diagnosis of prostate cancer by multiparametric MRI.
Dwivedi DK; Jagannathan NR
MAGMA; 2022 Aug; 35(4):587-608. PubMed ID: 35867236
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
